Requirements for the stimulation of allogeneic T lymphocytes by acute non-lymphoblastic leukaemia cells
- PMID: 2960448
- PMCID: PMC11038661
- DOI: 10.1007/BF00199155
Requirements for the stimulation of allogeneic T lymphocytes by acute non-lymphoblastic leukaemia cells
Abstract
Blast cell populations from 32 patients with acute non-lymphoblastic leukaemia of various morphological types have been examined for their ability to stimulate allogeneic T lymphocytes from normal donors in one-way mixed leucocyte culture (MLC). At the same time, these leukaemic cell populations were examined for the amounts of major histocompatibility complex Class I and Class II antigens they expressed, and their ability to release interleukin 1 (IL1) in culture both with and without stimulation by lipopolysaccharide. The abilities of the leukaemic cell populations to stimulate in MLC, and to produce IL1, were found to be associated with the expression of morphological characteristics of monocytic differentiation, and correlated significantly. In contrast, no correlation was observed between the extent of Class I or Class II expression and MLC stimulatory ability. Many myeloblast populations of immature phenotype were unable to stimulate allogeneic T cells despite their strong expression of these antigens. This lack of stimulatory ability was not overcome by the addition of exogenous IL1. We therefore conclude that the correlation between the production of IL1 and MLC stimulatory ability does not necessarily imply a cause/effect relationship, and that the interaction between allo-antigen and the T cell receptor together with a supply of lymphokine 'co-stimulator' is not sufficient to activate resting T lymphocytes. The failure of some Class I and II antigen positive leukaemic blasts to stimulate in MLC even in the presence of exogenous IL1 may be due to the lack of other differentiation-associated cell surface molecules necessary for stable cell-cell interaction.
Similar articles
-
HL-60 myeloid leukaemia cells acquire immunostimulatory capability upon treatment with retinoic acid: analysis of the responding population and mechanism of cytotoxic lymphocyte activation.Immunology. 1996 Jul;88(3):428-40. doi: 10.1046/j.1365-2567.1996.d01-668.x. Immunology. 1996. PMID: 8774361 Free PMC article.
-
Stimulatory ability of human leukaemic cells in the allogeneic mixed leucocyte reaction.Aust J Exp Biol Med Sci. 1983 Aug;61 (Pt 4):477-88. doi: 10.1038/icb.1983.45. Aust J Exp Biol Med Sci. 1983. PMID: 6228214
-
Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.Immunology. 1978 Aug;35(2):299-305. Immunology. 1978. PMID: 155646 Free PMC article.
-
CD80-Transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens.Blood. 1998 Sep 1;92(5):1677-84. Blood. 1998. PMID: 9716596
-
Accessory cells and T cell activation. The relationship between two components of macrophage accessory cell function: I-A and IL1.Immunobiology. 1984 Dec;168(3-5):213-31. doi: 10.1016/S0171-2985(84)80112-6. Immunobiology. 1984. PMID: 6241599 Review.
Cited by
-
HL-60 myeloid leukaemia cells acquire immunostimulatory capability upon treatment with retinoic acid: analysis of the responding population and mechanism of cytotoxic lymphocyte activation.Immunology. 1996 Jul;88(3):428-40. doi: 10.1046/j.1365-2567.1996.d01-668.x. Immunology. 1996. PMID: 8774361 Free PMC article.
References
-
- Abo T, Balch CM. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1) J Immunol. 1981;127:1024–1029. - PubMed
-
- Ashman LK. Stimulatory ability of human leukaemic cells in the allogeneic mixed leucocyte reaction. Aust J Exp Biol Med Sci. 1983;61:477–488. - PubMed
-
- Ashman LK. Proliferative response of normal and activated human lymphocytes to tetradecanoyl phorbol acetate. Cell Immunol. 1984;87:613–625. - PubMed
-
- Ashman LK. The immunogenicity of tumour cells. Immunol Cell Biol. 1987;65:271–277. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials